Articles tagged with Ribosomes
The American Association of Anatomists has awarded three young investigators for groundbreaking research in cell biology, comparative neuroanatomy, and developmental biology. Maria Barna, Gloria Brar, and Shigeki Watanabe have made significant contributions to biomedical science through their research.
Researchers at IBS discovered a new function of DNA repair protein SHPRH, which regulates ribosome synthesis in response to nutrient availability. The protein's behavior changes during cellular starvation, allowing it to quickly recover ribosome production upon nutrient reintroduction.
A new study discovered a chemical compound that selectively stalls the production of specific proteins by targeting the ribosome. This approach offers a promising strategy for treating diseases, including cancer and cardiovascular disease.
Researchers have discovered a chemical compound that selectively stalls the ribosome, halting the production of specific proteins while leaving general protein production untouched. This discovery suggests a new approach to finding drugs that target undesired proteins before they are made.
Researchers found that reducing calorie consumption slows down ribosome production, giving cells extra time to repair themselves and maintaining overall bodily function. This study provides insights into the mechanisms of aging and may help inform decisions about diet and nutrition.
Researchers at Caltech have discovered the molecular basis for protection of a ribosomal protein from cellular degradation, using X-ray crystallography to solve the structure of the bound pair. This finding has potential applications in developing new cancer drugs by preventing tumor growth.
A team of scientists has identified a crucial step in the protein-sorting process, revealing that the signal recognition particle (SRP) recognizes membrane proteins before they are fully synthesized. This discovery highlights the importance of ribosomal tunnels in coordinating protein transport and sorting.
Two specific proteins recognize defective mRNAs and trigger their destruction, maintaining cell survival. The study reveals a direct competition-based approach for targeting aberrant ribosomes.
A new quality control system in cells has been identified, which recognizes and destroys faulty genetic material by targeting the ribosome and messenger RNA. This discovery could potentially be used to develop new treatments for genetic diseases.
Researchers from Lomonosov Moscow State University demonstrate how an evolutionary ancient mechanism of protein biosynthesis helps a cell resist stress. They developed a technique called FLERT, which allows studying the impact of cell stress on protein synthesis in a short-time scale.
Research reveals that 20-40% of multiple myeloma patients have a defective ribosome, leading to a poorer prognosis but better response to Bortezomib treatment. The discovery has the potential to improve therapy selection for these patients.
Researchers at Ludwig-Maximilians-Universität München discovered a mechanism to recycle bacterial ribosomes stalled on messenger RNAs lacking termination codons. This process, involving the protein ArfA, has emerged as a promising target for developing new antibiotics.
The discovery by University of Konstanz researchers reveals two regions within Ssb that mediate direct contact with the ribosome, supporting its function. The findings suggest a unique feature of Ssb that enables it to position itself optimally at the ribosome.
Scientists used cutting-edge imaging and computational tools to decipher the assembly process of ribosomes, revealing multiple routes for assembly and parallel pathways. This discovery has significant implications for understanding diseases and developing safer medicines.
The 'Iron Hammer' protein complex plays a crucial role in splitting the two subunits of the ribosome after protein synthesis is complete. The researchers used advanced techniques to reveal the structure of this complex and its interaction with the small ribosomal subunit.
Researchers at the University of Pennsylvania have identified a new mechanism by which RNA molecules are degraded in plants, occurring co-translationally with translation. This process is linked to gene regulation and may play a role in stress response.
Researchers found that ribosomes hold newly synthesized proteins back until specific helpers, called chaperones, deliver the matching counterparts. This ensures only the intended structure is formed, adopting the role of a quality inspector in addition to production.
Selenium's incorporation into selenoproteins requires a unique elongation factor called eEFSec that helps recognize the stop codon as coding for selenocysteine. The discovery sheds light on how selenium is handled differently during protein synthesis due to its high reactivity.
A new understanding of protein creation based on RNA recipes reveals great precision in cell diversity and efficiency in ribosome reading. The research also sheds light on the interaction between ribosomes and RNA during tumor formation, potentially leading to better treatments.
Researchers at the University of Leeds have solved a 25-year-old question about how bacteria resist certain antibiotics. The study provides direct evidence that ABC-F proteins 'protect' the bacterial ribosome, allowing it to continue making proteins despite antibiotic presence.
Researchers developed compound inhibitors that target ribosomes in the translation phase of a virulent bacteria's genetic process. These compounds halt the bacterial rescue operation, making it difficult for the bacteria to grow and proliferate. The study's findings offer new hope against biowarfare agents and resistant pathogens.
Researchers at MSU clarify how living cells determine the start of protein synthesis, introducing a new facet to the mechanism. The discovery reveals that GTP hydrolysis plays a crucial role in determining whether a ribosome recognizes an AUG codon or not.
A new method called RiboTaper helps to clarify the function of unknown genes by analyzing sequencing data. By filtering out background noise, researchers can determine which genes are actively producing proteins and identify specific points on RNA where significant events occur.
Researchers at Georgia Tech use ribosomal RNA to trace life's evolution, finding molecular structures and events near the biochemical origins of life. By analyzing variations in ribosomal RNA, they uncover secrets of creation and answer foundational questions about life's origins.
Researchers found that ribosomes can translate the 'untranslated region' of mRNA, producing small proteins whose functions are unknown. This discovery opens up new questions about cancer cell growth and how cells respond to stress.
Researchers created a tethered artificial ribosome called Ribo-T, which works nearly as well as the natural cellular component. The engineered ribosome enables production of new drugs and biomaterials, and may lead to better understanding of ribosome function.
Researchers found that yeast modify their genomes to produce more ribosomes in response to excess calories, enabling faster replication and optimal growth. This study reveals a new mechanism by which organisms can adapt to environmental changes.
Decaying RNA molecules provide a snapshot of how proteins are produced, with one end decaying while the other serves as a template for translation. Researchers have discovered that an enzyme degrading mRNA follows closely behind ribosomes, pausing at set points to allow translation to complete before degradation begins.
Scientists have identified a new chaperone protein, Acl4, that helps assemble ribosomal protein L4 into a developing ribosome. This discovery provides insights into the stepwise process of ribosome assembly and has potential applications in antifungal agents and disease research.
Researchers at UC Berkeley have identified a new target for cancer drugs in messenger RNA molecules, which carry unique tags that can be targeted to regulate translation. These tagged mRNAs play a key role in controlling cell growth and differentiation, making them potential targets for new anticancer therapies.
Researchers have developed a new fluorescence microscopy technique that shows where and when proteins are produced in individual cells. The technique allows direct observation of messenger RNA molecules being translated into proteins, shedding light on protein synthesis irregularities contributing to human diseases.
Scientists from the Scripps Research Institute have confirmed that ribosome assembly is a potentially fertile new target for anti-cancer drugs. The study highlights the essential function of Casein kinase 1δ (CK1δ) and CK1ε in human ribosome assembly, which are also elevated in several tumor types and neurodegenerative diseases.
Scientists have found evidence that ribosomes are not just passive translators of DNA but also have their own genetic information and may be responsible for creating proteins. The discovery challenges traditional views on the evolution of life and suggests a new spin on feeling kinship with other creatures.
A team of researchers discovered a protein called Rqc2 that specifies which amino acids are added to stalled proteins, blurring the lines of what we thought proteins could do. The study suggests potential implications for neurodegenerative diseases such as Alzheimer's, ALS, or Huntington's.
Research reveals that damaged messenger RNA can cause ribosomes to jam, leading to the production of short proteins and contributing to neurodegenerative diseases. Oxidized mRNA was found to accumulate in cells with advanced Alzheimer's, highlighting a potential mechanism for the disease.
Researchers describe the Terasaki ramps in the endoplasmic reticulum as spiral structures that connect parallel sheets, allowing for high density of ribosomes. This geometry is stable and minimizes energy, consistent with the laminar structure of the stacks.
Researchers at ETH Zurich have studied the molecular structure of mitoribosomes, revealing new details about how proteins are synthesized. The findings will help design antibiotics that target only bacterial ribosomes, improving their effectiveness in treating human diseases.
A new class of antibiotics could be developed using the anticonvulsant drug lamotrigine, which inhibits bacterial ribosome assembly. Researchers at McMaster University discovered that lamotrigine stops ribosomes from being created in bacteria, a breakthrough in tackling antibiotic resistance.
Scientists at the University of Rochester have isolated key steps in ribosome formation, a crucial process for bacterial growth. The researchers found that multiple pathways of RNA processing occur simultaneously, suggesting new possibilities for stopping super-bugs.
USC Stem Cell scientists have created a transgenic mouse line called TRAP, which enables the detection of early signals of acute kidney injury. This breakthrough has the potential to improve patient outcomes by detecting kidney failure earlier, allowing for more effective treatment.
Researchers at the University of Maryland have discovered a new process in human genes that can alter protein contents and functions. This process, known as programmed ribosomal frameshifting, may help the body regulate its immune response and prevent harmful side effects.
Researchers model primordial ribosomes using modern structures, showing how new structures were added to the surface without altering the core. The study reveals the universal biology of translation, with distinct fingerprints in ribosomes across species.
Researchers at UC San Diego have discovered a specialized system that enables the synthesis of ribosomal proteins, which are crucial for producing life-sustaining proteins. This finding has significant implications for understanding cell growth and development, and may lead to new treatments for diseases such as cancer.
Biologists at UC San Diego found the missing link to protein factory production, revealing a novel regulatory system that produces ribosomal proteins. This discovery provides new insights into controlling cell growth and potentially treating diseases like cancer.
Researchers discovered a comprehensive catalogue of proteins manufactured in specific parts of Purkinje neurons using cutting-edge methods TRAP and CAGEscan. This finding holds key to understanding molecular events and potential insights into diseases associated with Purkinje cells.
Fragile X syndrome is caused by the absence of FMRP protein, which regulates cell machinery responsible for producing functional proteins. The study found that FMRP binds directly to ribosomes in cells, regulating protein expression and providing insights into potential novel therapies.
Researchers discovered how Fragile X mental retardation protein affects brain cell protein production, leading to the development of potential therapies for the genetic disorder. The study identified a critical binding site on the ribosome that could be targeted by drugs.
Researchers have identified hundreds of open reading frames in long non-coding RNAs that may give rise to functional proteins using ribosome profiling. The method allowed direct quantification of messenger RNA fragments protected by the ribosome, revealing translated small open reading frames.
A new study reveals that defective ribosomes are the root cause of human diseases, starting with anemia and bone marrow failure early in life. As quality control systems fail, more ribosomes become available, leading to changes in gene expression patterns that can result in cancer.
Researchers have made a computer app to spot and decode the unique footprints in yeast DNA, revealing an intricately choreographed dance of ribosomal RNA genes. This discovery enables biologists to track evolutionary relationships between different species using these tiny changes.
Researchers at Johns Hopkins Medicine used a powerful data-crunching technique to understand how the protein Dom34 keeps defective genetic material from disrupting cellular functions. The study found that Dom34 'rescues' protein-making factories called ribosomes when they get stuck obeying defective genetic instructions.
A new study reports that the ribosome's small subunit assembles itself through a dynamic interaction between proteins and RNA. The team discovered that a specific protein plays a crucial role in this process, allowing for the binding of subsequent proteins.
Researchers at ETH Zurich deciphered the structure of the large subunit of the mitochondrial ribosome, a complex enzyme that deciphers genetic code and assembles amino acids into proteins. The study's success relies on a combination of high-resolution cryo-electron microscopy and chemical cross-linking combined with mass spectrometry.
Stanford researchers have made a breakthrough in developing a universal flu vaccine by targeting the protein stem rather than the head of a critical protein. This approach aims to offer broader protection against different strains of flu and potential multi-season immunity.
Scientists at EMBL have discovered that pairs of tags are added to RNA molecules in a specific order, helping control folding and ribosome formation. This complex choreography allows cells to precisely regulate protein factories.
The study found that mutant RBS cells exhibited aberrant ribosome malfunction, leading to upregulation of p53 protein and strong inhibition of mTOR signaling. Supplementing L-leucine partially rescued defects in both human skin cells and zebrafish embryos carrying the mutated ESCO2 gene.
Researchers at the University of Rochester have discovered a unique way in which naked mole rats build proteins, leading to nearly perfect protein structures and reduced error rates. This breakthrough could one day lead to pharmaceutical treatments that improve protein synthesis in humans.
Researchers analyzed the riboproteome to gain a better understanding of translation and its impact on cancer. The study uncovered dynamic components of the ribosome that can be altered in cancer, highlighting potential therapeutic targets.
Researchers at Uppsala University have identified the ribosome as a key player in prion diseases, such as mad cow disease and Creutzfeldt-Jakob disease. The discovery suggests that antiprion medicines targeting the ribosome's protein folding activity may be effective in treating these fatal neurodegenerative diseases.
Scientists have successfully synthesized ribosomes from scratch using a novel technology that mimics the natural process. This breakthrough enables the creation of functional ribosomes with exotic functions and could lead to the discovery of new antibiotics and modified protein-generators.